Literature DB >> 10818591

Plasma DNA K-ras mutations in patients with gastrointestinal malignancies.

H E Mulcahy1, J Lyautey, C Lederrey, X Q Chen, F Lefort, V Vasioukhin, P Anker, E M Alstead, M J Farthing, M Stroun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10818591     DOI： 10.1111/j.1749-6632.2000.tb06585.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.

Authors:  A V Lichtenstein; O I Serdjuk; T I Sukhova; H S Melkonyan; S R Umansky
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

Authors:  Jin Li; Lyndsay Harris; Harvey Mamon; Matthew H Kulke; Wei-Hua Liu; Penny Zhu; G Mike Makrigiorgos
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

3.  Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.

Authors:  Thomas E Liggett; Anatoliy A Melnikov; Jeffrey R Marks; Victor V Levenson
Journal:  Int J Cancer       Date:  2010-04-05       Impact factor: 7.396

4.  Detection of hypermethylated vimentin in urine of patients with colorectal cancer.

Authors:  Benjamin P Song; Surbhi Jain; Selena Y Lin; Quan Chen; Timothy M Block; Wei Song; Dean E Brenner; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2012-01-16       Impact factor: 5.568

5.  Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.

Authors:  Rihong Zhai; Yang Zhao; Li Su; Lauren Cassidy; Geoffrey Liu; David C Christiani
Journal:  Neoplasia       Date:  2012-01       Impact factor: 5.715

6.  Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer.

Authors:  Ying-Hsiu Su; Mengjun Wang; Dean E Brenner; Alan Ng; Hovsep Melkonyan; Samuil Umansky; Sapna Syngal; Timothy M Block
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

7.  Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.

Authors:  Yi-Xin Hao; Qiang Fu; Yan-Yan Guo; Ming Ye; Hui-Xia Zhao; Qi Wang; Xiu-Mei Peng; Qiu-Wen Li; Ru-Liang Wang; Wen-Hua Xiao
Journal:  Onco Targets Ther       Date:  2017-02-16       Impact factor: 4.147

8.  The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.

Authors:  Wenli Xie; Li Xie; Xianrang Song
Journal:  Cancer Med       Date:  2019-02-21       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.